Sanyou Medical

Shanghai Sanyou Medical Co., Ltd. was established in 2005 as a medical device enterprise specializing in the research, development, production, and sales of orthopedic implant consumables for medical use. The company's main products are spinal implant consumables and trauma implant consumables. It is one of the few companies in China’s spinal implant consumables field with the original innovation capability to address clinical needs. The company's stock abbreviation is Sanyou Medical, and its stock code is 688085.Since its establishment, the company has placed great emphasis on product updates and iterations. Under the leadership of Dr. Michael Mingyan Liu, the chairman, the company has built a complete product R&D system and owns internationally advanced R&D equipment and project management systems, ensuring that the company’s products remain advanced, effective, and reliable. As of January 31, 2020, the company holds 22 Class III medical device product registration certificates and 112 patents, including 28 domestic invention patents, 81 domestic utility model patents, 1 U.S. invention patent, 1 German utility model patent, and 1 design patent. The company and its products have received numerous honors, such as the First Prize of Scientific Progress Award from the Outstanding Achievement Award for Scientific Research of Higher Education Institutions, the Second Prize of Medical Science and Technology Award from the Chinese Medical Association, Shanghai Pilot Enterprise for Patent Work, Shanghai Excellent Medical Device Products, and Shanghai Science and Technology Giant Enterprise.In the future, the company will continue to rely on national policies encouraging the innovation of domestically produced medical device products. Taking this STAR Market listing as an opportunity, it will continuously increase investment in R&D, maintain its leading position in China’s spinal consumables field, strive to significantly increase market share, further enrich and improve its orthopedic product series, and continuously enhance the company’s value to achieve sustainable, healthy, rapid development and maximize investor benefits.